Removing fallopian tubes to lower ovarian cancer risk
Salpingectomy for Ovarian Cancer Risk Reduction: Improving Utilization and Informed Decision-Making
This study is looking at how removing fallopian tubes can help lower the risk of ovarian cancer and aims to find out why doctors might not suggest this option to patients, while also helping women understand its benefits better.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10932137 on NIH RePORTER |
What this research studies
This research investigates the benefits of prophylactic salpingectomy, which involves the removal of fallopian tubes while preserving the ovaries, as a method to reduce the risk of ovarian cancer. The study aims to identify barriers that prevent healthcare providers from recommending this procedure and to enhance patient awareness regarding its potential benefits. By focusing on improving decision-making and utilization of salpingectomy, the research seeks to promote better preventive care for women at risk of ovarian cancer. The findings could lead to increased adoption of this safer alternative to traditional prophylactic ovary removal.
Who could benefit from this research
Good fit: Ideal candidates for this research are women who are considering sterilization or those at increased risk for ovarian cancer.
Not a fit: Patients who have already undergone hysterectomy with ovary removal or those without risk factors for ovarian cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce the incidence of ovarian cancer in women while minimizing the negative health impacts associated with surgical menopause.
How similar studies have performed: Previous research has indicated that salpingectomy can effectively reduce ovarian cancer risk, suggesting that this approach has potential for success.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Xu, Xiao — Columbia University Health Sciences
- Study coordinator: Xu, Xiao
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.